TRIM11 and Alzheimer disease: These findings enable new, promising approaches for AD therapy options, as a recent study showed that Tripartite motif-containing protein 11 (TRIM11) is downregulated in AD and that AAV-based viral delivery of TRIM11 confers strong protection against TAU pathology in several mouse models [46].